30
/es/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
3512555
319423
2
Public Timelines FAQ
Public TimelinesFAQ
Public TimelinesFAQ
For educational institutions For teachers For students Open cabinet
For educational institutions For teachers For students Open cabinet
Crear
Create a timeline
Public timelines
Library
FAQ

1 ene 2006 año - NCI's Study of Tamoxifen and Raloxifene (STAR)

Descripción:

Results from NCI's Tamoxifen and Raloxifene study show that postmenopausal women at increased risk of breast cancer may reduce their risk of developing the disease if they take raloxifene as an antiestrogen medication. The risk of serious side effects of raloxifene is lower than that of tamoxifen.

Añadido al timeline:

Cancer

ByTrinity Ozias
14 nov 2019

fecha:

1 ene 2006 año
Ahora mismo
~ 18 years ago
About & FeedbackAcuerdoPrivacidadBiblioteca
2024 © Time.Graphics
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Excellent (Trustpilot Reviews)
Based on 115+ reviews